Podium Abstract
Eposter Presentation
 
Accept format: PDF. The file size should not be more than 5MB
 
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
 
Submitted
Abstract
Predictive analysis of new chronic renal impairment after pelvic exenteration in an Australian quaternary centre
Podium Abstract
Clinical Research
Oncology: Urethra/ Penis/ Testes/ Sarcoma/ Miscellaneous
Author's Information
10
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Australia
Jordan Santucci santuccijordan@gmail.com Royal Melbourne Hospital Melbourne Australia *
Niranjan Sathianathen niranjan19@gmail.com Austin Health Melbourne Australia -
Michael Bozin mike.bozin@petermac.org Royal Melbourne Hospital Melbourne Australia -
Jacob McCormick Jacob.McCormick@mh.org.au Royal Melbourne Hospital Melbourne Australia -
Helen Mohan helen.mohan@petermac.org Peter MacCallum Cancer Centre Melbourne Australia -
Satish Warrier Satish.Warrier@petermac.org Peter MacCallum Cancer Centre Melbourne Australia -
Declan Murphy declan.murphy@petermac.org Peter MacCallum Cancer Centre Melbourne Australia -
Alexander Heriot alexander.heriot@petermac.org Peter MacCallum Cancer Centre Melbourne Australia -
Marlon Perera marlonlperera@gmail.com Peter MacCallum Cancer Centre Melbourne Australia -
Nathan Lawrentschuk lawrentschuk@gmail.com Royal Melbourne Hospital Melbourne Australia -
 
 
 
 
 
 
 
 
 
 
Abstract Content
Pelvic exenteration (PE) including the radical en-block resection of at least two adjacent pelvic organs, regional lymph nodes and pelvic side wall is a major uro-oncological undertaking with frequent morbidity. This study aims to assess the rate of new chronic renal impairment, predictive factors, and association with urological intervention after PE at an Australian quaternary centre.
Patients who underwent PE with a genitourinary component at a single quaternary referral centre between January 2003 and July 2021 were included in this analysis. Data were collected prospectively over this time and analysed retrospectively. Complications were defined as early (< 30 days) or late (≥ 30 days), and were classified according to the Clavien-Dindo classification. Multivariable binary logistic regression was performed to determine predictors of chronic renal impairment (defined as any new renal impairment from baseline persisting 3 or more months, or an increase in CKD stage from baseline).
Overall, 424 patients underwent PE, of whom 213 (50.2%) had a genitourinary component. Median post-operative length of stay was 21.5 (IQR 15.3-32) days. Early post-operative (30-day) mortality was 0.5% and overall mortality at a median follow-up of 22.7 months was 40.4%. An early urological complication occurred in 106 (49.8%) patients, a late urological complication eventuated in 56 (26.3%) patients. Chronic kidney disease developed post-operatively in 39 (18.3%) patients at the completion of patient follow-up, with three patients requiring nephrectomy for loss of function of a single renal unit. Female sex and primary (as opposed to recurrent) malignancy were the only statistically significant predictors of new chronic renal impairment (OR [95% CI] 2.86 (1.33-6.16) and 2.18 (1.09-4.34), respectively).
Our experience with PE over a long follow-up period demonstrates urological complication rates consistent with the literature associated with urinary diversion and anastomosis. There were no modifiable risk factors for new chronic renal impairment after PE identified on multivariable regression analysis. Further research is required to delineate and mitigate risk factors for chronic renal impairment after PE.
Pelvic exenteration, genitourinary outcomes, genitourinary complications, chronic kidney disease, predictive analysis
https://storage.unitedwebnetwork.com/files/1237/a8f30540ba9c8801cc01278ca666c905.png
Bolded OR statistically significant with a 95% CI not crossing 1. Abbreviations: OR = odds ratio. CI = confidence interval.
 
 
 
 
 
 
 
 
1811
 
Presentation Details
Free Paper Podium(26): Oncology Miscellaneous & Endourology (C)
Aug. 17 (Sun.)
14:12 - 14:18
8